findmyKOL
Clinical trialNCT01306032CompletedPhase 2Interventional

Phase II ABT-888 With Cyclophosphamide

SponsorNational Cancer Institute (NCI)Enrollment124Fallopian Tube CancerOvarian CancerPrimary Peritoneal CancerSerous Carcinoma CancerTriple-Negative Breast Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Princess Margaret Hospital

    Toronto, Ontario, Canada

United States
  • University of California, Davis

    Davis, California, United States

  • H. Lee Moffitt Cancer Center & Research Institute

    Tampa, Florida, United States

  • University of Chicago

    Chicago, Illinois, United States

  • National Institutes of Health Clinical Center, 9000 Rockville Pike

    Bethesda, Maryland, United States

  • Mayo Clinic, Rochester

    Rochester, Minnesota, United States

  • Memorial Sloan Kettering Cancer Center

    New York, New York, United States

  • Montefiore Medical Center

    The Bronx, New York, United States

  • Ohio State University

    Columbus, Ohio, United States

  • Md Anderson Cancer Center

    Houston, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
12 Jan 2011
Primary completion
31 Dec 2014
Completion
15 Dec 2016
Last update posted
26 Apr 2017
Registered enrollment
124
Registry id
NCT01306032

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.